SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-116486
Filing Date
2014-03-26
Accepted
2014-03-26 16:12:08
Documents
3
Period of Report
2014-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d699701d8k.htm 8-K 14393
2 EX-99.1 d699701dex991.htm EX-99.1 86240
3 GRAPHIC g699701snap0006.jpg GRAPHIC 6527
  Complete submission text file 0001193125-14-116486.txt   110865
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 14718772
SIC: 2834 Pharmaceutical Preparations